These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28879805)

  • 1. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
    Robinson SD; Undheim EAB; Ueberheide B; King GF
    Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide therapeutics from venom: Current status and potential.
    Pennington MW; Czerwinski A; Norton RS
    Bioorg Med Chem; 2018 Jun; 26(10):2738-2758. PubMed ID: 28988749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in venom peptide drug discovery: where are we at and where are we heading?
    Smallwood TB; Clark RJ
    Expert Opin Drug Discov; 2021 Oct; 16(10):1163-1173. PubMed ID: 33914674
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological screening technologies for venom peptide discovery.
    Prashanth JR; Hasaballah N; Vetter I
    Neuropharmacology; 2017 Dec; 127():4-19. PubMed ID: 28377116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthroughs in Venom Peptide Screening Methods to Advance Future Drug Discovery.
    Napolitano T; Holford M
    Protein Pept Lett; 2018; 25(12):1137-1148. PubMed ID: 30381057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venoms as a platform for human drugs: translating toxins into therapeutics.
    King GF
    Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venomics-Accelerated Cone Snail Venom Peptide Discovery.
    Himaya SWA; Lewis RJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29522462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venomics: unravelling the complexity of animal venoms with mass spectrometry.
    Escoubas P; Quinton L; Nicholson GM
    J Mass Spectrom; 2008 Mar; 43(3):279-95. PubMed ID: 18302316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centipede venoms as a source of drug leads.
    Undheim EA; Jenner RA; King GF
    Expert Opin Drug Discov; 2016 Dec; 11(12):1139-1149. PubMed ID: 27611363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Venoms and medical research].
    Ducancel F
    Biol Aujourdhui; 2016; 210(2):89-99. PubMed ID: 27687600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins.
    Verdes A; Anand P; Gorson J; Jannetti S; Kelly P; Leffler A; Simpson D; Ramrattan G; Holford M
    Toxins (Basel); 2016 Apr; 8(4):117. PubMed ID: 27104567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale discovery of conopeptides and conoproteins in the injectable venom of a fish-hunting cone snail using a combined proteomic and transcriptomic approach.
    Violette A; Biass D; Dutertre S; Koua D; Piquemal D; Pierrat F; Stöcklin R; Favreau P
    J Proteomics; 2012 Sep; 75(17):5215-25. PubMed ID: 22705119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an integrated venomics approach for accelerated conopeptide discovery.
    Prashanth JR; Lewis RJ; Dutertre S
    Toxicon; 2012 Sep; 60(4):470-7. PubMed ID: 22564717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venom peptides as pharmacological tools and therapeutics for diabetes.
    Robinson SD; Safavi-Hemami H
    Neuropharmacology; 2017 Dec; 127():79-86. PubMed ID: 28689026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery.
    Herzig V; Cristofori-Armstrong B; Israel MR; Nixon SA; Vetter I; King GF
    Biochem Pharmacol; 2020 Nov; 181():114096. PubMed ID: 32535105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput expression of animal venom toxins in Escherichia coli to generate a large library of oxidized disulphide-reticulated peptides for drug discovery.
    Turchetto J; Sequeira AF; Ramond L; Peysson F; Brás JL; Saez NJ; Duhoo Y; Blémont M; Guerreiro CI; Quinton L; De Pauw E; Gilles N; Darbon H; Fontes CM; Vincentelli R
    Microb Cell Fact; 2017 Jan; 16(1):6. PubMed ID: 28095880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular-Active Venom Toxins: An Overview.
    Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
    Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in venomics: Modern separation techniques and mass spectrometry.
    Abd El-Aziz TM; Soares AG; Stockand JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122352. PubMed ID: 32971366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine-Based Selection of Drugs That Target Ion Channels from Combinatorial Venom Peptide Libraries.
    Zhang H; Du M; Xie J; Liu X; Sun J; Wang W; Xin X; Possani LD; Yea K; Lerner RA
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9306-10. PubMed ID: 27197631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and therapeutic potential of venom peptides.
    Robinson SD; Vetter I
    Biochem Pharmacol; 2020 Nov; 181():114207. PubMed ID: 32857993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.